Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

GATA4 Is a Critical Regulator of Senescence and Inflammation

DOI: 10.1158/2159-8290.CD-RW2015-192 Published December 2015
  • Article
  • Info & Metrics
Loading
  • Major finding: GATA4 induces the SASP and senescence via NFκB activation in response to DNA damage signaling.

  • Mechanism: GATA4 is normally degraded by p62-mediated selective autophagy, which is inhibited in senescent cells.

  • Impact: GATA4 accumulation in aging tissues may contribute to age-related diseases including cancer.

Cellular senescence is induced by various stresses, including DNA damage, oncogene activation, and recurrent proliferation, and has been suggested both to suppress tumorigenesis and, in other contexts, to contribute to aging and tumorigenesis. Senescence is characterized by growth arrest and increased expression of proinflammatory factors, known as the senescence-associated secretory phenotype (SASP), which is controlled by NFκB signaling. Autophagy has also been implicated in senescence and the SASP, but the mechanisms by which autophagy regulates senescence remain unclear. Kang and colleagues found that expression of the transcription factor GATA4, but not other members of the GATA family, upregulated the expression of senescence-associated genes, including many SASP genes, and induced senescence in human fibroblasts. GATA4 was degraded under normal conditions via interaction with p62 and selective autophagy, thereby inhibiting senescence; however, senescence-inducing stimuli suppressed selective autophagy, resulting in GATA4 stabilization, suggesting that autophagy both negatively and positively regulates senescence. Expression of GATA4 promoted the SASP via activation of NFκB, which was mediated in part via TNF receptor–associated factor 3–interacting protein 2 and IL1A. The GATA4 senescence pathway was activated by the DNA damage response (DDR) kinases ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR), but was independent of p53 and p16INNK4A/RB, core senescence pathways that are critical for senescence growth arrest, indicating that GATA4 functions as a distinct branch of the DDR that induces the SASP to facilitate senescence. Consistent with these findings, induction of senescence by ionizing radiation resulted in accumulation of GATA4 in mouse tissues in vivo. Furthermore, GATA4 expression was increased in the organs of aged mice compared with those of young animals, and was increased in brain samples from older humans. These findings identify GATA4 as a previously unidentified regulator of the SASP and senescence, and suggest that the GATA4 pathway may play a role in age-associated inflammation and pathologies such as cancer.

Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 2015;349:aaa5612.

  • ©2015 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 5 (12)
December 2015
Volume 5, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GATA4 Is a Critical Regulator of Senescence and Inflammation
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
GATA4 Is a Critical Regulator of Senescence and Inflammation
Cancer Discov December 1 2015 (5) (12) OF19; DOI: 10.1158/2159-8290.CD-RW2015-192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
GATA4 Is a Critical Regulator of Senescence and Inflammation
Cancer Discov December 1 2015 (5) (12) OF19; DOI: 10.1158/2159-8290.CD-RW2015-192
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
Show more Research Watch

Senescence

  • TIMP1 Determines the Effects of Cellular Senescence in Prostate Cancer
  • Aging-Related Defects in Oxidative Phosphorylation May Be Tumorigenic
  • Serum Methylmalonic Acid Mediates Aging-Related Cancer Aggressiveness
Show more Senescence
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement